Open Label Trial of Creatine as a Treatment Option for Methamphetamine Using Females

Tracy Lynn Hellem
Methamphetamine (MA) is a powerful drug that results in short- and long-term consequences for users. Study findings suggest that female MA users have higher rates of comorbid depression and anxiety than male MA users. Further, neuroimaging studies have found that female MA users have lower levels of brain phosphocreatine (PCr) measured by magnetic resonance spectroscopy (MRS) brain compared to male MA users. Treatment options for the comorbidity of depression and MA dependence are limited. The...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.